Illumina (NASDAQ:ILMN) Raised to Neutral at Citigroup
Citigroup upgraded shares of Illumina (NASDAQ:ILMN – Free Report) from a sell rating to a neutral rating in a research note released on Monday, MarketBeat Ratings reports. Citigroup currently has $120.00 target price on the life sciences company’s stock, up from their previous target price of $85.00. A number of other research firms have also […]
More Stories
Moleculin Biotech (NASDAQ:MBRX) Corporate Presentation Available OnlineOn January 8, 2025, Moleculin Biotech, Inc. (the “Company”) made public its corporate presentation, which is now accessible on the Company’s official website. The presentation det
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...
**Formula One Group Appoints Derek Chang as President and CEO**
Formula One Group, a subsidiary of Liberty Media Corporation (NASDAQ: FWONK), announced significant executive changes in a recent 8-K filing...
Asure Software, Inc. (NASDAQ:ASUR) Receives Average Rating of “Buy” from Analysts
Shares of Asure Software, Inc. (NASDAQ:ASUR – Get Free Report) have received a consensus rating of “Buy” from the seven...
Montage Gold Corp. (CVE:MAU) Receives Consensus Recommendation of “Buy” from Analysts
Shares of Montage Gold Corp. (CVE:MAU – Get Free Report) have received a consensus recommendation of “Buy” from the seven...
Analyzing Black Diamond Therapeutics (NASDAQ:BDTX) & Cardiol Therapeutics (NASDAQ:CRDL)
Cardiol Therapeutics (NASDAQ:CRDL – Get Free Report) and Black Diamond Therapeutics (NASDAQ:BDTX – Get Free Report) are both small-cap medical...
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Receives Consensus Rating of “Hold” from Analysts
Shares of Evolv Technologies Holdings, Inc. (NASDAQ:EVLV – Get Free Report) have received a consensus rating of “Hold” from the...